104 related articles for article (PubMed ID: 29936711)
21. Social differences in sexual behaviour and cervical cancer.
de Sanjosé S; Bosch FX; Muñoz N; Shah K
IARC Sci Publ; 1997; (138):309-17. PubMed ID: 9353671
[TBL] [Abstract][Full Text] [Related]
22. [Frequency of HPV infection of the uterine cervix among perimenopausal women in Wielkopolska Region].
Zietkowiak W; Zimna K; Sroka Ł; Uchman P; Sajdak S
Ginekol Pol; 2002 Nov; 73(11):939-44. PubMed ID: 12722378
[TBL] [Abstract][Full Text] [Related]
23. Human papillomavirus infection and P53 codon 72 genotypes in a Hispanic population at high-risk for cervical cancer.
Haws AL; Woeber S; Gomez M; Garza N; Gomez Y; Rady P; He Q; Zhang L; Grady JJ; McCormick JB; Fisher-Hoch SP; Tyring SK
J Med Virol; 2005 Oct; 77(2):265-72. PubMed ID: 16121365
[TBL] [Abstract][Full Text] [Related]
24. Human papillomavirus: often harmless but in some cases carcinogenic.
Prescrire Int; 2007 Jun; 16(89):115-9. PubMed ID: 17585425
[TBL] [Abstract][Full Text] [Related]
25. Prevalence and genotypes' distribution of human papillomavirus in invasive cervical cancer in Saudi Arabia.
Alsbeih G; Ahmed R; Al-Harbi N; Venturina LA; Tulbah A; Balaraj K
Gynecol Oncol; 2011 Jun; 121(3):522-6. PubMed ID: 21353296
[TBL] [Abstract][Full Text] [Related]
26. International correlation between human papillomavirus prevalence and cervical cancer incidence.
Maucort-Boulch D; Franceschi S; Plummer M;
Cancer Epidemiol Biomarkers Prev; 2008 Mar; 17(3):717-20. PubMed ID: 18349293
[TBL] [Abstract][Full Text] [Related]
27. Effectiveness of preventive human papillomavirus vaccination.
Lehtinen M; Paavonen J
Int J STD AIDS; 2003 Dec; 14(12):787-92. PubMed ID: 14678583
[TBL] [Abstract][Full Text] [Related]
28. Prevalence of papillomavirus infection in women in Ibadan, Nigeria: a population-based study.
Thomas JO; Herrero R; Omigbodun AA; Ojemakinde K; Ajayi IO; Fawole A; Oladepo O; Smith JS; Arslan A; Muñoz N; Snijders PJ; Meijer CJ; Franceschi S
Br J Cancer; 2004 Feb; 90(3):638-45. PubMed ID: 14760378
[TBL] [Abstract][Full Text] [Related]
29. Incidence of cervical human papillomavirus infection in systemic lupus erythematosus women.
Mendoza-Pinto C; García-Carrasco M; Vallejo-Ruiz V; Méndez-Martínez S; Taboada-Cole A; Etchegaray-Morales I; Muñóz-Guarneros M; Reyes-Leyva J; López-Colombo A
Lupus; 2017 Aug; 26(9):944-951. PubMed ID: 28059024
[TBL] [Abstract][Full Text] [Related]
30. Recommendations for cervical cancer prevention in Asia Pacific.
Garland SM; Cuzick J; Domingo EJ; Goldie SJ; Kim YT; Konno R; Parkin DM; Qiao YL; Sankaranarayanan R; Stern PL; Tay SK; Bosch FX
Vaccine; 2008 Aug; 26 Suppl 12():M89-98. PubMed ID: 18945418
[TBL] [Abstract][Full Text] [Related]
31. Cervical cancers associated with human papillomavirus types 16, 18 and 45 are diagnosed in younger women than cancers associated with other types: a cross-sectional observational study in Wales and Scotland (UK).
Powell N; Cuschieri K; Cubie H; Hibbitts S; Rosillon D; De Souza SC; Molijn A; Quint W; Holl K; Fiander A
J Clin Virol; 2013 Nov; 58(3):571-4. PubMed ID: 24051043
[TBL] [Abstract][Full Text] [Related]
32. Human papillomavirus (HPV) and cervical cancer.
Biswas A
J Indian Med Assoc; 2000 Feb; 98(2):53-5. PubMed ID: 11016151
[TBL] [Abstract][Full Text] [Related]
33. Prevaccination distribution of human papillomavirus types in Italian women with high-risk lesions and cervical neoplasia.
De Francesco MA; Gargiulo F; Schreiber C; Ciravolo G; Salinaro F; Manca N
Intervirology; 2010; 53(6):417-25. PubMed ID: 20606464
[TBL] [Abstract][Full Text] [Related]
34. [Molecular variants of human papillomaviruses types 16, 18, and 45 in tumors of the uterine cervix in Mexico].
Lizano M; García-Carrancá A
Gac Med Mex; 1997; 133 Suppl 1():43-8. PubMed ID: 9504102
[TBL] [Abstract][Full Text] [Related]
35. Cervical human papillomavirus infection in Tunisian women.
Hassen E; Chaieb A; Letaief M; Khairi H; Zakhama A; Remadi S; Chouchane L
Infection; 2003 Jun; 31(3):143-8. PubMed ID: 12789471
[TBL] [Abstract][Full Text] [Related]
36. [Genital human papillomavirus (HPV) infection in women in the province of Asti (Italy)].
Salfa MC; Bocci C; Lillo F; Regine V; Brunini S; Camoni L; Barbero M; Suligoi B
Ig Sanita Pubbl; 2011; 67(4):425-37. PubMed ID: 22033201
[TBL] [Abstract][Full Text] [Related]
37. Oropharyngeal squamous cell carcinoma and human papillomavirus-associated cancers in women: epidemiologic evaluation of association.
Biron VL; Côté DW; Seikaly H
J Otolaryngol Head Neck Surg; 2011 Feb; 40 Suppl 1():S65-9. PubMed ID: 21453664
[TBL] [Abstract][Full Text] [Related]
38. Human papillomavirus: present and future perspective in Saudi Arabia.
Elasbali AM
J Obstet Gynaecol; 2021 May; 41(4):497-502. PubMed ID: 32347771
[TBL] [Abstract][Full Text] [Related]
39. Epidemiological characteristics of cervical cancer in a tertiary care hospital, western Saudi Arabia: A retrospective record-based analysis from 2002-2018.
Farahat FM; Faqih NT; Alharbi RS; Mudarris RI; Alshaikh SA; Al-Jifree HM
Saudi Med J; 2021 Mar; 42(3):338-341. PubMed ID: 33632914
[TBL] [Abstract][Full Text] [Related]
40. Update knowledge on cervical cancer incidence and prevalence in Asia.
Daniyal M; Akhtar N; Ahmad S; Fatima U; Akram M; Asif HM
Asian Pac J Cancer Prev; 2015; 16(9):3617-20. PubMed ID: 25987011
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
